Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Reconnaissance of peculiar Research and Innovation on Cell and Gene Therapy
- Gene Therapy 2020

Welcome Message

With the grand success of Gene Therapy 2019, Allied Academies is proud to announce the "2nd International Conference on Cell and Gene Therapy” to be held during March 23-24, 2020 in Amsterdam, Netherlands.

We welcome all the attendees, speakers, sponsors and other research expertise from all over the world to the “2nd International Conference on Cell and Gene Therapy” which is going to be held during March 23-24, 2020 in Amsterdam, Netherlands. The eminent speakers and scientists of Cell Therapy, Gene Therapy, Stem cell Therapy, Viral Gene Therapy, Genetics & Genomic Medicine, Stem Cell Genetics and Genetic Engineering from around the globe is expected to share their knowledge.

The gathering may be an occasion that makes a perfect stage to share information and trending topics on Gene Therapy and also an impeccable step towards trading of gravitating topics in Cell and Gene Therapy. The participants can confirm their participation by registering for the conference along with their colleagues and avail the Early Bird Offer!

We hope you will gather us for a symphony of fascinating science and hold little extra time to enjoy the spectacular and unique beauty of this region.

Make your presence in our conference and share your knowledge with the academic, businesspeople that will double your ideas.

Regards

Organizing committee

Gene therapy 2020

Session/Track

Session onCell Therapy

Cell therapy or cytotherapy is that the transfer of cells into a patient with a goal of raising the illness. From starting blood transfusions were thought of to be the primary kind of cell therapy to be experienced as routine. Later, Bone Marrow Transplantation has conjointly become a well-established the conception that involves treatment of abundant quite blood disorders together with anemia, leukemia, cancer and rare immunological disorder diseases. Alternative medical practitioners perform cell therapy within the variety of many totally different names together with organ transplant therapy, organ therapy, and recent cell therapy.

Related: Gene Therapy Conferences | Gene Therapy Events | Gene therapy Meetings | Stem cells symposium | Molecular Biology summit | Cell Biology congress

Related Conferences: Congress of the European Society of Gene and Cell Therapy (ESGCT)

Barcelona, Spain, The Cell & Gene Therapy Strategy Meeting Europe Zurich, Switzerland, 21 – 25 October 2019, Therapy Manufacturing and Commercialization, Boston, MA, 10 - 13 September 2019, Annual conference of the British Society for Gene and Cell Therapy (BSGCT) Sheffield, UK, 25 - 26 June 2019

Related Associations and Societies: European Society of Gene and cell therapy |Foundation for the Accreditation of Cellular TherapyAlliance for Cancer Gene Therapy | Finnish Society of Gene TherapyFrench Society of Cell Therapy and Genetics | Austrian Network for Gene TherapyBritish Society of Gene Therapy (BSGT)Turkish society of Gene and cell therapySwedish society of Gene and cell therapySpanish society of Gene and cell therapy

Session onGene Therapy

Gene therapy is an exclusive technique employed in medical treatment that uses specific kinds of genes to treat many forms of diseases. Gene therapy is also used to treat several hereditary diseases, wherein the mutated the defective gene is replaced with the functional gene. Gene therapy is that the one that most huge topic administered by researchers everywhere the globe for the forestall or treatment of many diseases like immune deficiencies, hemophilia, Parkinson’s illness, cancer, and even HIV, through different approaches. The mutated disease-causing sequence with the healthy factor, inactivation of the mutated gene, and introduction of the new cistron to fight against the illness.

 Related: Gene Therapy symposium | Gene Therapy conference | Gene therapy Events | Stem cells Summit | Molecular Biology Conferences | Cell Biology Meetings

Related Conferences: Next-generation CAR & T Cell Therapies, San Francisco, CA, 19 - 21 June 2019, Advanced Therapy Medicinal Products Conference, Vilnius, Lithuania, 18 - 20 June 2019, NDD Europe - Neurodegenerative Drug Development - Focus on gene therapy, Paris, France, 25 - 26 May 2019, World Advanced Therapies & Regenerative Medicine Congress 2019, London, UK, 21 - 23 May 2019.

Related Associations and Societies: American Society of Human Genetics (ASHG) | World Health Organization | American Society of Human GeneticsAmerican Society for Cell Biology | Alliance for cellular signaling | American Society of Gene TherapyAmerican Association for Cancer ResearchAmerican Society of Gene and Cell Therapy

 Session onStem Cell Therapy

Cell therapy is outlined because the therapy during which cellular material is injected into a patient so as to recover the healthy tissue. Cell therapy is targeted at many clinical indications in multiple organs by means of several modes of cell delivery. Stem-Cell Therapy is the use of stem cells to treat or forestall illness or condition. Stem cells are a category of undifferentiated cells that are able to differentiate into needed or specialized cell sorts. Adult or corporeal stem cells exist throughout the body when embryonic development and are found accessible within the various forms of tissue. The stem cell methodology includes the phases of stem cell or primogenitor cell engraftment, differentiation followed by the long-run replacement of broken tissue.

Related: Gene Therapy Meeting | Gene Therapy Events | Gene therapy Summit | Stem cells Conferences | Molecular Biology Symposium | Cell Biology Conference

Related Conferences: Advancing Manufacture of Cell and Gene Therapies VI, Coronado,30 - 31 January 2019, Gene Therapy – Ready for the Market? Frankfurt am Main, Germany, 6 - 7 February 2019, American Society of Gene and Cell Therapy (ASGCT) 23th Annual Meeting, Boston, MA, 20 – 23 October 2019, 10th International Conference on Genomics and Molecular Biology May 21-23, 2018, Barcelona, Spain

Related Associations and Societies: Australian Gene and Cell Therapy SocietyKorean society of Gene and Cell Therapy | Japan Society of Gene Therapy | Israeli Society of Gene and Cell therapy | The International Centre for and Biotechnology | The Human Genome variation society | Australian Biotechnology AssociationAustralasian Proteomics Society  

Session onCell Therapy for Cardiovascular Disorders

Cardiovascular diseases became an increasing clinical issue globally. A new challenge within the treatment of the disorder is cellular transplantation or cellular cardiomyopathy. Acute ischaemic injury and chronic cardiomyopathies lead to permanent loss of cardiac tissue and ultimately heart failure. Current therapies wide aim to attenuate the pathological changes that occur once injury and to reduce risk factors of vas diseases. However, they are doing not improve the patient's quality of life or the prognosis over moderate. Different types of somatic cells are used for stem cell therapy.

Related: Gene Therapy Event | Gene Therapy Meeting | Gene therapy Conference | Stem cells Symposium Molecular Biology Conference | Cell Biology Conferences

Related Conferences: Congress of the European Society of Gene and Cell Therapy (ESGCT)

Barcelona, Spain, The Cell & Gene Therapy Strategy Meeting Europe Zurich, Switzerland, 21 – 25 October 2019, Cell & Gene Therapy Manufacturing and Commercialization, Boston, MA, 10 - 13 September 2019, Annual conference of the British Society for Gene and Cell Therapy (BSGCT) Sheffield, UK, 25 - 26 June 2019

Related Associations and Societies: European Society of Gene and cell therapy |Foundation for the Accreditation of Cellular TherapyAlliance for Cancer Gene Therapy | Finnish Society of Gene TherapyFrench Society of Cell Therapy and Genetics | Austrian Network for Gene TherapyBritish Society of Gene Therapy (BSGT)Turkish society of Gene and cell therapySwedish society of Gene and cell therapySpanish society of Gene and cell therapy

Session on: Cell Science and Stem Cell Research

The extract derived from the plant cell culture technology is being harnessed and utilized as an active ingredient in anti-aging skincare products. In recent years, researchers have known present botanicals with substantial inhibitor activity proved to safeguard skin stem cells from UV-induced aerophilic stress, inhibit inflammation, neutralize free radicals and reverse the effects of photoaging by means of antioxidant activity. Consequently, cosmeceutical merchandise containing plant stem cell-derived extracts have the power to market healthy cell proliferation and defend against UV-induced medical specialty cellular injury in humans. In distinction to epidemic stem cells, plant stem cells are the ability that they're capable of making a wholly new, whole plant.

Related: Gene Therapy Conferences | Gene Therapy Events | Gene therapy Meetings | Stem cells Symposium | Molecular Biology Summit | Cell Biology Conference

Related Conferences: Next-generation CAR & T Cell Therapies, San Francisco, CA, 19 - 21 June 2019, Advanced Therapy Medicinal Products Conference, Vilnius, Lithuania, 18 - 20 June 2019, NDD Europe - Neurodegenerative Drug Development - Focus on gene therapy, Paris, France, 25 - 26 May 2019, World Advanced Therapies & Regenerative Medicine Congress 2019, London, UK, 21 - 23 May 2019.

Related Associations and Societies: American Society of Human Genetics (ASHG) | World Health Organization | American Society of Human GeneticsAmerican Society for Cell Biology | Alliance for cellular signaling | American Society of Gene TherapyAmerican Association for Cancer ResearchAmerican Society of Gene and Cell Therapy

Session onViral Gene Therapy

 Classical methods of gene therapy include transfection. It became inefficient and restricted chiefly because of delivery of sequence into actively proliferating cells in-vitro. Gene therapy utilizes the delivery of deoxyribonucleic acid into cells by means that of vectors like biological in-vitro or infectious agent vectors and non-viral ways. The many forms of the virus’s vectors employed in sequence therapy are an animal virus, adeno-associated virus and herpes simplex virus. While alternative recombinant infectious agent vector systems are developed, retroviral vectors remain the foremost in style vector system for factor medical aid protocols.

Related: Gene Therapy Meeting | Gene Therapy Symposium | Gene therapy Meetings | Stem cells Conferences | Molecular Biology Summit | Cell Biology Conference

Related Conferences: Advancing Manufacture of Cell and Gene Therapies VI, Coronado,30 - 31 January 2019, Gene Therapy – Ready for the Market? Frankfurt am Main, Germany, 6 - 7 February 2019, American Society of Gene and Cell Therapy (ASGCT) 23th Annual Meeting, Boston, MA, 20 – 23 October 2019, 10th International Conference on Genomics and Molecular Biology May 21-23, 2018, Barcelona, Spain

Related Associations and Societies: Australian Gene and Cell Therapy SocietyKorean society of Gene and Cell Therapy | Japan Society of Gene Therapy | Israeli Society of Gene and Cell therapy | The International Centre for and Biotechnology | The Human Genome variation society | Australian Biotechnology AssociationAustralasian Proteomics Society

Session onTissue Science and Regenerative Medicine

Tissue Science is essentially study and understanding of however the tissue is organized during a complexed human system and its structure and functions of it. As we have a tendency to all recognize that every one the tissues are classified along to make the organ.so it’s all vital to an understanding regarding the tissues initial. Regenerative medicine is a part of the translational analysis in tissue engineering and biological science. it deals with the process of commutation, engineering or makes human cells, tissues or organs to revive or establish traditional function. This field contains the hope of engineering broken tissues and organs.

Related: Gene Therapy Conferences | Gene Therapy Symposium | Gene therapy Meetings | Stem cells Conference | Molecular Biology Summit | Cell Biology Event

Related Conferences: Congress of the European Society of Gene and Cell Therapy (ESGCT)

Barcelona, Spain, The Cell & Gene Therapy Strategy Meeting Europe Zurich, Switzerland, 21 – 25 October 2019, Cell & Gene Therapy Manufacturing and Commercialization, Boston, MA, 10 - 13 September 2019, Annual conference of the British Society for Gene and Cell Therapy (BSGCT) Sheffield, UK, 25 - 26 June 2019

Related Associations and Societies: European Society of Gene and cell therapy |Foundation for the Accreditation of Cellular TherapyAlliance for Cancer Gene Therapy | Finnish Society of Gene TherapyFrench Society of Cell Therapy and Genetics | Austrian Network for Gene TherapyBritish Society of Gene Therapy (BSGT)Turkish society of Gene and cell therapySwedish society of Gene and cell therapySpanish society of Gene and cell therapy

Sessions onMolecular Basis of Epigenetics

Epigenetics refers to changes in an exceedingly body that has an influence on the sequence activity and expression. It is also used to describe any heritable phenotypic change that doesn't derive from a modification of the chromosome such as prions. Epigenetics is the mechanism for storing and perpetuating or continued indefinitely a memory at the cellular level. The basic molecular epigenetic mechanisms that are widely studied at the present – regulation of chromatin granule structure of cell through simple protein post-translational modifications and valence modification of deoxyribonucleic acid primarily through the method of DNA methylation.

Related: Gene Therapy Conferences | Gene Therapy Summit | Gene therapy Meetings | Stem cells Event | Molecular Biology Symposium | Cell Biology Conference

Related Conferences: Next-generation CAR & T Cell Therapies, San Francisco, CA, 19 - 21 June 2019, Advanced Therapy Medicinal Products Conference, Vilnius, Lithuania, 18 - 20 June 2019, NDD Europe - Neurodegenerative Drug Development - Focus on gene therapy, Paris, France, 25 - 26 May 2019, World Advanced Therapies & Regenerative Medicine Congress 2019, London, UK, 21 - 23 May 2019.

Related Associations and Societies: American Society of Human Genetics (ASHG) | World Health Organization | American Society of Human GeneticsAmerican Society for Cell Biology | Alliance for cellular signaling | American Society of Gene TherapyAmerican Association for Cancer ResearchAmerican Society of Gene and Cell Therapy

 Session on: Bioengineering Therapeutics

Tissue engineering is the combinatory usage of cells, engineering, materials ways, appropriate organic chemistry, and chemical science factors so as to enhance or replace the infected biological tissues. Tissues or cells, signal early changes in health standing and supply implantable bioartificial replacement organs to recover or establish healthy tissue. Techniques developed here determine and discover biomarkers of sickness sub-types, progression, and treatment response, from tissue imaging, gene testing and sequence analysis, that aid the additional fast development of recent treatments and guide their clinical applications in treating the disorder.

Related: Gene Therapy Events | Gene Therapy Meeting | Gene therapy Meetings | Stem cells Symposium | Molecular Biology Conferences | Cell Biology Conference

Related Conferences: Advancing Manufacture of Cell and Gene Therapies VI, Coronado,30 - 31 January 2019, Gene Therapy – Ready for the Market? Frankfurt am Main, Germany, 6 - 7 February 2019, American Society of Gene and Cell Therapy (ASGCT) 23th Annual Meeting, Boston, MA, 20 – 23 October 2019, 10th International Conference on Genomics and Molecular Biology May 21-23, 2018, Barcelona, Spain

Related Associations and Societies: Australian Gene and Cell Therapy SocietyKorean society of Gene and Cell Therapy | Japan Society of Gene Therapy | Israeli Society of Gene and Cell therapy | The International Centre for and Biotechnology | The Human Genome variation society | Australian Biotechnology AssociationAustralasian Proteomics Society

Session onClinical Trials on Gene Therapy

Clinical trials of gene therapy product usually varied from the clinical trial's style for alternative forms of the pharmaceutical product. These variations in trial style are necessitated by the distinctive options of those products. The clinical trials additionally replicate previous clinical expertise and proof of drugs. Early experiences with product indicate that some sequence therapy product could create substantial risks to subjects because of the impact on the cellular and genetic level. The design of early-phase clinical trials of Gene therapy products often involves the following consideration of clinical safety issues, preclinical issues, and chemistry, manufacturing, and controls (CMC) issues that are encountered.

Related: Gene Therapy Conference | Gene Therapy Events | Gene therapy Symposium | Stem cells Meeting | Molecular Biology Summit | Cell Biology Conferences

Related Conferences: Congress of the European Society of Gene and Cell Therapy (ESGCT)

Barcelona, Spain, The Cell & Gene Therapy Strategy Meeting Europe Zurich, Switzerland, 21 – 25 October 2019, Cell & Gene Therapy Manufacturing and Commercialization, Boston, MA, 10 - 13 September 2019, Annual conference of the British Society for Gene and Cell Therapy (BSGCT) Sheffield, UK, 25 - 26 June 2019

Related Associations and Societies: European Society of Gene and cell therapy |Foundation for the Accreditation of Cellular TherapyAlliance for Cancer Gene Therapy | Finnish Society of Gene TherapyFrench Society of Cell Therapy and Genetics | Austrian Network for Gene TherapyBritish Society of Gene Therapy (BSGT)Turkish society of Gene and cell therapySwedish society of Gene and cell therapySpanish society of Gene and cell therapy

 Session onAdvanced Gene Therapy

Therapeutics is the branch of science addressing the appliance of remedies of diseases. Moving on to the sequence therapeutics it is the medication that we tend to develop a remedy for illness through the genetic material. Advanced sequence therapeutics could be a medication we tend to use the medicine to treat an illness by developing indefinite quantity forms to optimize drug action, underpin new formulations that focus on molecules spatially among the body, enhance the bioequivalence of poorly soluble medicine and biologics, and improve patient expertise and compliance.

Related: Gene Therapy Conferences | Gene Therapy Summit | Gene therapy Meetings | Stem cells Conference | Molecular Biology Symposium | Cell Biology Event

Related Conferences: Next-generation CAR & T Cell Therapies, San Francisco, CA, 19 - 21 June 2019, Advanced Therapy Medicinal Products Conference, Vilnius, Lithuania, 18 - 20 June 2019, NDD Europe - Neurodegenerative Drug Development - Focus on gene therapy, Paris, France, 25 - 26 May 2019, World Advanced Therapies & Regenerative Medicine Congress 2019, London, UK, 21 - 23 May 2019.

Related Associations and Societies: American Society of Human Genetics (ASHG) | World Health Organization | American Society of Human GeneticsAmerican Society for Cell Biology | Alliance for cellular signaling | American Society of Gene TherapyAmerican Association for Cancer ResearchAmerican Society of Gene and Cell Therapy

Session onGenetics & Genomic Medicine

Genetics in Health and disease at intervals that therapy utilizes genetics, imaging and biological indicators to understand predisposition to unwellness, what constitutes health throughout childhood and throughout the life course. Gene and macromolecule perform are wont to develop tools, skills, and resources to elucidate factor perform and to tell the development of recent therapies victimization state-of-the-art technologies. Personalized medication and Patient profit is taken into account to make sure basic science discoveries of illness mechanisms and patient’s genomes are wont to turn out the best result to boost patients’ lives that include higher medical specialty, identification of biomarkers and targeting of therapies.

Related: Gene Therapy Conferences | Gene Therapy Events | Gene therapy Meetings | Stem cells Conferences | Molecular Biology Conferences | Cell Biology Conferences

Related Conferences: Advancing Manufacture of Cell and Gene Therapies VI, Coronado,30 - 31 January 2019, Gene Therapy – Ready for the Market? Frankfurt am Main, Germany, 6 - 7 February 2019, American Society of Gene and Cell Therapy (ASGCT) 23th Annual Meeting, Boston, MA, 20 – 23 October 2019, 10th International Conference on Genomics and Molecular Biology May 21-23, 2018, Barcelona, Spain

Related Associations and Societies: Australian Gene and Cell Therapy SocietyKorean society of Gene and Cell Therapy | Japan Society of Gene Therapy | Israeli Society of Gene and Cell therapy | The International Centre for and Biotechnology | The Human Genome variation society | Australian Biotechnology AssociationAustralasian Proteomics Society

 Session on: Genome Editing Technology

Genome editing technology deals with designed nucleases and it's the rising form of genetic engineering. it is the technology within which the DNA is inserted, deleted or replaced within the order. The emergence of very versatile genome-editing technologies has provided investigators with the malleability to quickly and economically introduce sequence-specific modifications into the genomes of the broad spectrum of cell types and organisms. It additionally promotes varied changes in the subcellular level. Genome piece of writing itself additionally holds tremendous potential for treating the underlying numerous upset genetic causes of sure diseases.

Related: Gene Therapy Event | Gene Therapy Symposium | Gene therapy Summit | Stem cells Conferences | Molecular Biology Meeting | Cell Biology Conference

Related Conferences: Congress of the European Society of Gene and Cell Therapy (ESGCT)

Barcelona, Spain, The Cell & Gene Therapy Strategy Meeting Europe Zurich, Switzerland, 21 – 25 October 2019, Cell & Gene Therapy Manufacturing and Commercialization, Boston, MA, 10 - 13 September 2019, Annual conference of the British Society for Gene and Cell Therapy (BSGCT) Sheffield, UK, 25 - 26 June 2019

Related Associations and Societies: European Society of Gene and cell therapy |Foundation for the Accreditation of Cellular TherapyAlliance for Cancer Gene Therapy | Finnish Society of Gene TherapyFrench Society of Cell Therapy and Genetics | Austrian Network for Gene TherapyBritish Society of Gene Therapy (BSGT)Turkish society of Gene and cell therapySwedish society of Gene and cell therapySpanish society of Gene and cell therapy

Session onGenetic Engineering

Genome editing with designed nucleases (GEEN) is an emerging sort of genetic engineering. GEEN is that the technology within which deoxyribonucleic acid is inserted, deleted or replaced within the genome. The emergence of extremely versatile genome-editing technologies has provided investigators with the power to quickly and economically introduce sequence-specific modifications into the genomes of a broad spectrum of cell types and organisms. It additionally promotes numerous changes in subcellular level. Genome written material itself additionally holds tremendous potential for treating the underlying numerous disorder genetic causes of sure diseases.

Related: Gene Therapy Conferences | Gene Therapy Events | Gene therapy Symposium | Stem cells Meeting | Molecular Biology Summit | Cell Biology Conference

Related Conferences: Next-generation CAR & T Cell Therapies, San Francisco, CA, 19 - 21 June 2019, Advanced Therapy Medicinal Products Conference, Vilnius, Lithuania, 18 - 20 June 2019, NDD Europe - Neurodegenerative Drug Development - Focus on gene therapy, Paris, France, 25 - 26 May 2019, World Advanced Therapies & Regenerative Medicine Congress 2019, London, UK, 21 - 23 May 2019.

Related Associations and Societies: American Society of Human Genetics (ASHG) | World Health Organization | American Society of Human GeneticsAmerican Society for Cell Biology | Alliance for cellular signaling | American Society of Gene TherapyAmerican Association for Cancer ResearchAmerican Society of Gene and Cell Therapy

 Session onCell & Gene therapy for rare and common disease

Gene therapy is employed to treat genetic Muscular disorder, vessel disorder, HIV, cancer, etc. In stem cell transplants, stem cells replace cells broken by therapy or unwellness or as the way for the donor's system to impress immunity against some varieties of cancer and blood-related diseases, such as leukemia. Cellular therapy is internationally recognized for its novel approaches in treating blood connected disorders like leukemia, lymphoma, myeloma, and alternative critical diseases. The stem cell transplantation of hemopoietic stem cells (HSCT) during which the allogeneic hemopoietic stem cells are harvested from healthy donors of the same species and autologous stem cell from the patient itself. Both therapies use high indefinite-quantity cytotoxic medication so as to induce higher remission rates against malignant diseases.

Related: Gene Therapy Conferences | Gene Therapy Events | Gene therapy Meetings | Stem cells Summit | Molecular Biology Symposium | Cell Biology Conference

Related Conferences: Advancing Manufacture of Cell and Gene Therapies VI, Coronado,30 - 31 January 2019, Gene Therapy – Ready for the Market? Frankfurt am Main, Germany, 6 - 7 February 2019, American Society of Gene and Cell Therapy (ASGCT) 23th Annual Meeting, Boston, MA, 20 – 23 October 2019, 10th International Conference on Genomics and Molecular Biology May 21-23, 2018, Barcelona, Spain

Related Associations and Societies: Australian Gene and Cell Therapy SocietyKorean society of Gene and Cell Therapy | Japan Society of Gene Therapy | Israeli Society of Gene and Cell therapy | The International Centre for and Biotechnology | The Human Genome variation society | Australian Biotechnology AssociationAustralasian Proteomics Society

Session onMarket and Future Prospect for Gene Therapy

The enormous number of companies involved in cell therapy has increased progression remarkably during the past few years. More than five hundred corporations are known to be concerned in cell therapy and 305 of those are profiled 291 alliances. Of these corporations, 170 are involved in stem cells. basing on the data gathered seventy-two tutorial establishments within the USA concerned in cell therapy at the side of their business collaborations allogenic technology with over 350 clinical trials are poised to dominate the exploitation of cell therapies in the market. Further, R and D in cell and sequence therapy is anticipated to bloom given the biologically based mostly benefits.

Related: Gene Therapy Symposium | Gene Therapy Events | Gene therapy Summit | Stem cells Conference | Molecular  Biology Conference | Cell Biology Meeting

Related Conferences: Congress of the European Society of Gene and Cell Therapy (ESGCT)

Barcelona, Spain, The Cell & Gene Therapy Strategy Meeting Europe Zurich, Switzerland, 21 – 25 October 2019, Cell & Gene Therapy Manufacturing and Commercialization, Boston, MA, 10 - 13 September 2019, Annual conference of the British Society for Gene and Cell Therapy (BSGCT) Sheffield, UK, 25 - 26 June 2019

Related Associations and Societies: European Society of Gene and cell therapy |Foundation for the Accreditation of Cellular TherapyAlliance for Cancer Gene Therapy | Finnish Society of Gene TherapyFrench Society of Cell Therapy and Genetics | Austrian Network for Gene TherapyBritish Society of Gene Therapy (BSGT)Turkish society of Gene and cell therapySwedish society of Gene and cell therapySpanish society of Gene and cell therapy.

Global Market Study

Market Analysis:

Gene therapy is a change, of course, out to be a captivating market for the companies and investors. In the global market, the gene therapy value is increasing gradually. The advent of an advanced technique for gene transfer has enabled the use of gene therapy for various new applications. The relative quantity of gene therapy products is in pre-clinical or clinical research. Till the day of the month, there are only four marketed drugs namely, Glybera, Neovasculogen, Gendicine, Rexin-G, and Oncorine. Yet, these products comprise very less revenue to the gene therapy market. The leading gross of the gene therapy market is generated from the products used in the clinical trials.

Market Value on Cell and Gene Therapy:

The worldwide stem cell therapy market is awaited to range $330 million by 2020, at a CAGR of 39.5% from 2015 to 2020. The stem cell market over the globe in 2015is expected to be dominated by North America, followed by Asia-Pacific and Europe. However, the Asia-pacific market is expected to surpass North America by 2020, owing to the high number of ongoing research activities. Autologous Stem Cell and Non-Stem Cell-Based Therapies market is currently estimated at $650 million, including products of all application areas. This market is anticipated to reach $2.2 billion by 2017, growing at a CAGR of 21%. Autologous Stem Cell and Non-Stem Cell-Based Therapies Market, Revenue Forecast


The market value of Cell & Gene Therapy

The gene therapy market is difficult to estimate as there is only one approved gene therapy product and it is marketed in China. Gene therapy markets are figuring for the period 2014-2024. The estimates are based on the epidemiology of diseases to be treated with gene therapy, the portion of those who will be eligible for these treatments, competing technologies and the technical developments anticipated in the next decades.

Products manufactured by the industry related cell therapy and its market Value:

Global markets for stem cells by BCC Research (2012), cited by Ministry of Food and Drug Safety predicted the global market size of stem cell therapy product would be 6.6 billion dollars in 2016 and grow 11.7% on average every year. Currently, the US's stem cell therapy product occupying the biggest market share amounts to 1.3 billion dollars and Europe's is 872 million dollars. US's stem cell therapy product market is predicted to have an average the annual growth rate of 11.5% (2.3 billion dollars in 2016), and Europe's is 10.9% (1.5 billion dollars in 2016). Until August 1, 2013, three stem cell therapies have acquired a sale permit for domestic use in Korea: Hearticellgram-AMI by FCB-Phamicell (the world's first stem cell therapy product), Cartistem, 24 medicines are still under the clinical trial reported by medipost.

Global markets for gene therapy product:


US$3 billion state taxpayer-funded institute for stem cell research, the California Institute for Regenerative Medicine. It hopes to provide $300 million a year. However, on June 6, 2006, there were delays in the implementation of the California program and it is believed that the delays will continue for the significant future.  On July 21, 2006, Governor Arnold Schwarzenegger (R-Calif.) approved $150 million in loans to the Institute in an attempt to jump-start the process of financial support research.

The Series A funding is led by MPM Capital, with Fidelity Biosciences, ARCH Venture Partners and Medtronic participating.  US provides $41 Million to SF start-up firms through Small Business Innovation Research Grant Scheme. Three SF Universities is financially banking from the NIH of US$ 258 Million.

Top Major Societies Associated with Cell and Gene Therapy

British Society of Gene and Cell Therapy

American Society of Gene and Cell Therapy (ASGCT)

Australasian Gene Therapy Society (AGTS)

Austrian Network for Gene Therapy

British Society of Gene Therapy (BSGT)

European Society of Gene and Cell Therapy (ESGCT)

Finnish Gene Therapy Society (FGTS)

German Gene Therapy Society (DGGT)

International Society for Cancer Gene Therapy (ISCGT)

Irish Society for Gene & Cell Therapy (ISGCT)

Israeli Society of Gene & Cell Therapy (ISGCT)

Japan Society of Gene Therapy (JSGT)

Korean Society of Gene and Cell Therapy (KSGCT)

Netherlands Society of Gene and Cell Therapy (NVGCT)

Spanish Society of Gene and Cell Therapy (SETGyC)

Swedish Society for Gene and Cell Therapy (SSGCT)

Turkish Society of Gene & Cell Therapy (TSGCT)

 

 Top Research Institutes of Cell and Gene Therapy Globally


Past Conference Report

 With the enormous pleasure, we would like to thank all the keynote speakers, plenary speakers, young researchers, students, business delegates and media partners for making Gene Therapy 2019 a glorious and victorious event.

AAC hosted a joint event of  International Conference on Cell & Gene Therapy 2019 and 2nd World Congress on Stem Cells and Regenerative and World Congress on Tissue Engineering and Regenerative during March 14-15, 2019 at Sheraton Heathrow Hotel, London, the United Kingdom with the theme “Explore the Novel Research on Cell and Gene Therapy” and  “Breakthrough Research and Technology for Stem Cells and Regenerative Medicine” and “Novel Perspectives on Tissue Engineering and Regenerative Medicine”. Gracious response and active participation were received from the Editorial Board Members of supporting International Journals as well as from the leading academic scientists, researchers, research scholars, students and leaders from the fields of  Cells and Gene Therapy who made this event successful.

The Scientists, Business Delegates, Young researchers marked the attendance at the conference representing more than 15 countries, have driven the conference path to great success.

The conference abstracts were given with DOI numbers in the Journal of Biomedical Research: Current Research. The conference was embarked with an opening ceremony followed by a series of interesting keynote and plenary lectures delivered by both Honorable guests and members of the organizing committee. Finally, the day ended up with Poster sessions and a student was given with the best poster award as judged by the keynote speakers.

The conference enlightened the various areas of Cells and Gene Therapy with a keynote, plenary, young researcher forum and poster presenters from various universities and organizations like:

West Virginia University | USA

REGEMAT 3D | Spain                                                          

University of Johannesburg | South Africa

V B S Purvanchal University | India

Princess Nourah Bint Abdul Rahman University | Saudi Arabia

Beirut Arab University | Lebanon

Ankara University | Turkey

Loughborough University | UK

University of Bradford | UK

Hochschule Furtwangen University | Germany

Workshops were conducted by:

Heidi Abrahamse | University of Johannesburg | South Africa

Alok Kumar Dash | V B S Purvanchal University | India

Once again, we would like to thank our fabulous Organizing committee members and the attendees for their gracious presence by facilitating the who supported the conference with active discussion forums and assistance towards the success of Gene Therapy 2019.

Gene Therapy 2019 with its grand success, AAC is happy to announce that the “2nd International Conference on Cell and Gene Therapy during March 23-24, 2020, Amsterdam,  Netherlands.

For more information please visit: http://genetherapy.alliedacademies.com

Organizing Committee
OCM Member
Dr. Ian Martins
Centre of Excellence for Alzheimer's Disease Research and Care Sarich Neuroscience Research Institute
Melbourne, Australia
OCM Member
Prof. Dimitrios P. Nikolelis
Laboratory of Environmental Chemistry Athens University
Athens, Greece
Venue
&
Hospitality

Registration Benefits:

Only Registration Includes:

  • Access to All Sessions and Workshops
  • CPD accredited
  • A free paper abstract in our Journal for free of cost
  • Accepted Abstracts will be published in respective supporting journals, 
    each abstract will be labeled with a DOI provided by Cross Ref.
  • Certificate of presentation by the International Organizing Committee (IOCM) 
  • Reception banquet
  • Coffee break during the conference
  • 2 days breakfast during the conference
  • 2 days Lunch during the conference
  • Handbook & Conference Kit
  • Lunch during the conference
  • Certificate of Presentation
  • B2B meetings

Package A

  • Accommodation for 2 nights: September 08-09, 2019
  • Above all only registration benefits
  • Free access to Wi-Fi

Package B

  • Accommodation for 3 nights: September 08-10, 2019
  • Above all only registration benefits
  • Free access to Wi-Fi

Book your Accommodation Now 

Click here for Registration 

For Group registration

Contact: Scarlet Emma (Program Director)

celltherapy@alliedforums.org

Join The Discussion

Allied Academies Global Conference Directory

Mail us at

Program Enquiry
cellgenetherepy@geneconferences.com
General Queries
cellgenetherepy@alliedforums.org
Sponsors/Exhibiting/Advertising
sponsoraac@alliedacademies.com
More details about sponsorship:sponsors@alliedacademies.com

Highlights from last year's Convention

Copyright © 2020-2021 Allied Academies, All Rights Reserved.